Home › Peripheral Arterial Disease
Peripheral Arterial Disease clinical trials recruiting in the U.S.
69 studies for Peripheral Arterial Disease are recruiting participants at sites across the United States.
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
Cities with the most studies
- Chicago, IL9 studies
- Dallas, TX9 studies
- Boston, MA9 studies
- Cleveland, OH9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Omaha, NE7 studies
- Nashville, TN6 studies
- Aurora, CO6 studies
- Minneapolis, MN6 studies
- Miami, FL6 studies
- New Haven, CT5 studies
- Norfolk, VA5 studies
- Detroit, MI5 studies
- Providence, RI5 studies
- Atlanta, GA5 studies
- Houma, LA5 studies
- Greenville, SC5 studies
- New York City, NY5 studies
- Philadelphia, PA5 studies
- Durham, NC4 studies
- Milwaukee, WI4 studies
- Tampa, FL4 studies
- Columbus, OH4 studies
- Tucson, AZ4 studies
- Plano, TX4 studies
- Orlando, FL4 studies
- Oklahoma City, OK4 studies
- Washington, DC4 studies
- Portland, OR4 studies
- Richmond, VA4 studies
- Los Angeles, CA4 studies
- Knoxville, TN4 studies
- Rochester, MN3 studies
- Raleigh, NC3 studies
- Pittsburgh, PA3 studies
- Phoenix, AZ3 studies
- San Diego, CA3 studies
- San Antonio, TX3 studies
- St. Petersburg, FL3 studies
By state
- Alabama4 studies
- Arizona9 studies
- Arkansas3 studies
- California13 studies
- Colorado8 studies
- Connecticut7 studies
- Florida17 studies
- Georgia6 studies
- Illinois11 studies
- Indiana4 studies
- Iowa4 studies
- Kentucky3 studies
- Louisiana9 studies
- Maryland4 studies
- Massachusetts11 studies
- Michigan9 studies
- Minnesota9 studies
- Missouri5 studies
- Nebraska8 studies
- New Hampshire3 studies
- New Jersey6 studies
- New York8 studies
- North Carolina9 studies
- Ohio14 studies
- Oklahoma5 studies
- Oregon4 studies
- Pennsylvania10 studies
- Rhode Island5 studies
- South Carolina7 studies
- Tennessee14 studies
- Texas20 studies
- Virginia10 studies
- Wisconsin6 studies
Recently updated studies
EVERO Drug-coated Balloon (DCB) Randomized Trial
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07144150Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07318610Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Detecting Peripheral Artery Disease With the Pulse
RecruitingHealthy volunteers welcome
Ages 19 and older · All sexes · Updated Sep 17, 2026 · NCT07226193Advanta VXT and Flixene PMCF Registry
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07161583Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07322913Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Recruiting
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07613840Community-based Exercise Following Revascularization for PAD
Recruiting
Ages 40 to 90 · All sexes · Updated Sep 9, 2026 · NCT04252950Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06437028The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Recruiting
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06321575Leg Heat Therapy in Peripheral Artery Disease
Recruiting
Ages 50 and older · All sexes · Updated Aug 17, 2026 · NCT05465070CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT05145478Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
RecruitingObservational study
Ages 22 and older · All sexes · Updated Aug 11, 2026 · NCT07335341Response to Exercise and Nitric Oxide in PAD
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Jul 27, 2026 · NCT06657976Vascular Trial Associated Registry Pilot
RecruitingPhase 4
Ages 45 and older · All sexes · Updated Jul 16, 2026 · NCT07076082Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
Recruiting
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07353905Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Jul 2, 2026 · NCT06544135The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Jun 29, 2026 · NCT07619885Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
RecruitingEarly phase 1Healthy volunteers welcome
Ages 50 to 75 · All sexes · Updated Jun 24, 2026 · NCT06319339Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Recruiting
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06300450The THOR IDE Study
Recruiting
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05916950The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
Recruiting
Ages 40 and older · All sexes · Updated May 29, 2026 · NCT05712395The COCOA-PAD II Trial
RecruitingPhase 3
Ages 55 and older · All sexes · Updated May 28, 2026 · NCT04794530The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Recruiting
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT05811364From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.